FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2179853997> ?p ?o ?g. }

• W2179853997 endingPage "77" @default.
• W2179853997 startingPage "669" @default.
• W2179853997 abstract "Vascular-targeted therapy is gradually becoming more appealing for patients with lung cancer. It is unclear whether vascular endothelial growth factor receptor 2 (VEGFR2) and neuropilin-1 (NRP-1) can be biomarkers for clinical treatment. We aimed to investigate the expression levels of VEGFR2 and NRP-1 in human non-small cell lung cancer (NSCLC) and their clinical significance by observing patient prognosis.VEGFR2 and NRP-1 were assessed by immunohistochemistry (IHC) in 40 patients with NSCLC and in 10 patients with benign lesions of lung; kinase insert domain receptor (KDR) and NRP-1 copy number gain (CNG) was assessed by fluorescence in situ hybridization (FISH). The distributions of overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method and compared between groups by log-rank test.Rates of positive immunostaining for VEGFR2 and NRP-1 were 58% and 55%, respectively. KDR and NRP-1 CNG (+) were detected in 32.5% and 30% of tumors, respectively. Levels of both VEGFR2 and NRP-1 in lung tumors were significantly different than in the control tissue (χ(2)=11.22, P=0.001; χ(2)=9.82, P=0.001, respectively); similar results were obtained using CNGs (χ(2)=4.39, P=0.036; χ(2)=3.95, P=0.046, respectively). Statistically significant correlations were observed with histological grade, clinical TNM stage and the lymph node status (P<0.05), but not age, gender or pathology type (P>0.05). VEGFR2 showed a strong correlation with NRP-1 (Rs=0.68, P=0.00); similar results were observed with KDR and NRP-1 CNG (Rs=0.32, P=0.04). Significant differences in OS and PFS were observed between the groups with higher VEGFR2 and NRP-1 and those with lower expression (P<0.05).According to these data, VEGFR2 and NRP-1 are highly expressed in NSCLC. We can conclude that they play a key role in NSCLC occurrence, development and metastasis and are associated with patient prognosis (P<0.05 for OS and PFS). This information will be beneficial for clinical anti-angiogenic treatment in NSCLC." @default.
• W2179853997 created "2016-06-24" @default.
• W2179853997 creator A5003105897 @default.
• W2179853997 creator A5003554962 @default.
• W2179853997 creator A5008659449 @default.
• W2179853997 creator A5048067765 @default.
• W2179853997 creator A5068301710 @default.
• W2179853997 creator A5078008730 @default.
• W2179853997 date "2014-12-01" @default.
• W2179853997 modified "2023-10-18" @default.
• W2179853997 title "Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance." @default.
• W2179853997 cites W1967114357 @default.
• W2179853997 cites W1979538859 @default.
• W2179853997 cites W2003240567 @default.
• W2179853997 cites W2010092400 @default.
• W2179853997 cites W2039589738 @default.
• W2179853997 cites W2040935952 @default.
• W2179853997 cites W2041320722 @default.
• W2179853997 cites W2043498865 @default.
• W2179853997 cites W2053358407 @default.
• W2179853997 cites W2082146700 @default.
• W2179853997 cites W2087523741 @default.
• W2179853997 cites W2129802084 @default.
• W2179853997 cites W2134530418 @default.
• W2179853997 cites W2155630513 @default.
• W2179853997 cites W2158734599 @default.
• W2179853997 cites W4290247175 @default.
• W2179853997 cites W92307352 @default.
• W2179853997 doi "https://doi.org/10.3978/j.issn.1000-9604.2014.12.04" @default.
• W2179853997 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4279211" @default.
• W2179853997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25561764" @default.
• W2179853997 hasPublicationYear "2014" @default.
• W2179853997 type Work @default.
• W2179853997 sameAs 2179853997 @default.
• W2179853997 citedByCount "20" @default.
• W2179853997 countsByYear W21798539972016 @default.
• W2179853997 countsByYear W21798539972018 @default.
• W2179853997 countsByYear W21798539972019 @default.
• W2179853997 countsByYear W21798539972020 @default.
• W2179853997 countsByYear W21798539972021 @default.
• W2179853997 countsByYear W21798539972022 @default.
• W2179853997 countsByYear W21798539972023 @default.
• W2179853997 crossrefType "journal-article" @default.
• W2179853997 hasAuthorship W2179853997A5003105897 @default.
• W2179853997 hasAuthorship W2179853997A5003554962 @default.
• W2179853997 hasAuthorship W2179853997A5008659449 @default.
• W2179853997 hasAuthorship W2179853997A5048067765 @default.
• W2179853997 hasAuthorship W2179853997A5068301710 @default.
• W2179853997 hasAuthorship W2179853997A5078008730 @default.
• W2179853997 hasConcept C126322002 @default.
• W2179853997 hasConcept C142724271 @default.
• W2179853997 hasConcept C143998085 @default.
• W2179853997 hasConcept C146285616 @default.
• W2179853997 hasConcept C146357865 @default.
• W2179853997 hasConcept C14858245 @default.
• W2179853997 hasConcept C151730666 @default.
• W2179853997 hasConcept C167734588 @default.
• W2179853997 hasConcept C204232928 @default.
• W2179853997 hasConcept C2776256026 @default.
• W2179853997 hasConcept C2777025900 @default.
• W2179853997 hasConcept C2780849966 @default.
• W2179853997 hasConcept C4224716 @default.
• W2179853997 hasConcept C63363279 @default.
• W2179853997 hasConcept C71924100 @default.
• W2179853997 hasConcept C86803240 @default.
• W2179853997 hasConceptScore W2179853997C126322002 @default.
• W2179853997 hasConceptScore W2179853997C142724271 @default.
• W2179853997 hasConceptScore W2179853997C143998085 @default.
• W2179853997 hasConceptScore W2179853997C146285616 @default.
• W2179853997 hasConceptScore W2179853997C146357865 @default.
• W2179853997 hasConceptScore W2179853997C14858245 @default.
• W2179853997 hasConceptScore W2179853997C151730666 @default.
• W2179853997 hasConceptScore W2179853997C167734588 @default.
• W2179853997 hasConceptScore W2179853997C204232928 @default.
• W2179853997 hasConceptScore W2179853997C2776256026 @default.
• W2179853997 hasConceptScore W2179853997C2777025900 @default.
• W2179853997 hasConceptScore W2179853997C2780849966 @default.
• W2179853997 hasConceptScore W2179853997C4224716 @default.
• W2179853997 hasConceptScore W2179853997C63363279 @default.
• W2179853997 hasConceptScore W2179853997C71924100 @default.
• W2179853997 hasConceptScore W2179853997C86803240 @default.
• W2179853997 hasIssue "6" @default.
• W2179853997 hasLocation W21798539971 @default.
• W2179853997 hasOpenAccess W2179853997 @default.
• W2179853997 hasPrimaryLocation W21798539971 @default.
• W2179853997 hasRelatedWork W2142528392 @default.
• W2179853997 hasRelatedWork W2337429573 @default.
• W2179853997 hasRelatedWork W2360518795 @default.
• W2179853997 hasRelatedWork W2362082229 @default.
• W2179853997 hasRelatedWork W2377907586 @default.
• W2179853997 hasRelatedWork W2378315212 @default.
• W2179853997 hasRelatedWork W2383391132 @default.
• W2179853997 hasRelatedWork W2386729272 @default.
• W2179853997 hasRelatedWork W2391101152 @default.
• W2179853997 hasRelatedWork W2392124124 @default.
• W2179853997 hasVolume "26" @default.
• W2179853997 isParatext "false" @default.
• W2179853997 isRetracted "false" @default.

• next